Nano-sized Drug Delivery Systems for Targeted Therapy of Chronic Diseases
American Journal Of Nano Science And Technology · 29.02.2024 · 5 (1) · 13-17
DOI: 10.71465/ajnst.1775 ↗Kurz gefasst
Fachartikel in der Zeitschrift American Journal Of Nano Science And Technology, online erschienen am 29.02.2024. Verfasst von Dr. Elena Kovalevskaya. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Nano-sized drug delivery systems have emerged as a transformative approach in the treatment of chronic diseases, offering precision, enhanced bioavailability, and reduced systemic toxicity. These nanocarriers, including liposomes, dendrimers, polymeric nanoparticles, and solid lipid nanoparticles, provide controlled release and site-specific targeting, especially valuable in managing diseases such as cancer, diabetes, and cardiovascular disorders. This paper reviews the current advancements in nano-sized drug delivery systems, their mechanisms of action, material design, and clinical outcomes. We discuss how functionalized nanocarriers improve therapeutic indices, extend circulation time, and cross physiological barriers. Finally, the article explores regulatory hurdles and future directions for nanotherapeutics in chronic disease treatment.
Zitieren
APA
Kovalevskaya, D. E. (2024). Nano-sized Drug Delivery Systems for Targeted Therapy of Chronic Diseases. American Journal Of Nano Science And Technology, 5(1), 13-17. https://doi.org/10.71465/ajnst.1775
Vancouver
Kovalevskaya DE. Nano-sized Drug Delivery Systems for Targeted Therapy of Chronic Diseases. American Journal Of Nano Science And Technology. 2024;5(1):13-17. doi:10.71465/ajnst.1775
BibTeX
@article{Kovalevskaya2024,
author = {Kovalevskaya, Dr. Elena},
title = {Nano-sized Drug Delivery Systems for Targeted Therapy of Chronic Diseases},
journal = {American Journal Of Nano Science And Technology},
year = {2024},
volume = {5},
number = {1},
pages = {13--17},
doi = {10.71465/ajnst.1775}
}
EUVIMED